Salivary mucin as related to oral Streptococcus mutans in elderly people.

Salivary mucin as related to oral Streptococcus mutans in elderly people. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Salivary mucin as related to oral Streptococcus mutans in elderly people. Abstract Text:

L W Baughan,F J Robertello,D C Sarrett,P A Denny,P C Denny,

MG1 (MUC5b and MUC4) and MG2 (MUC7), predominant mucins in human whole saliva, provide lubrication and antimicrobial protection for oral tissues. This study examines potential relationships between Streptococcus mutans titers in the oral cavity and the following: mucin concentrations; unstimulated and stimulated whole saliva flow rates; decayed, missing, and filled tooth surfaces; and age of 24 elderly patients. S. mutans titers were determined using Denticult SM. Mucin concentrations were determined using Stains-all, sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Logistic regression was used to identify potential relationships between the above variables. S. mutans classification served as the dependent variable. The remaining variables were possible predictor variables. The best model for predicting S. mutans category contained log MG2 as a predictor variable for all of its parameter estimates. No other set of parameter estimates were statistically significant. These results suggest that elevated S. mutans titers are significantly associated with diminished concentrations of MG2 in unstimulated whole saliva, as quantified in mucin-dye binding units.

Salivary mucin as related to oral Streptococcus mutans in elderly people. Publishing Authors By Initials

LW Baughan,FJ Robertello,DC Sarrett,PA Denny,PC Denny,

For similar bacteria: gram-positive bacteria: gram-positive cocci: streptococcaceae: streptococcus: viridans streptococci: streptococcus mutans research abstracts see: bacteria: gram-positive bacteria: gram-positive cocci: streptococcaceae: streptococcus: viridans streptococci: streptococcus mutans research

PUBMED ID PMID:

MEDLINE DATE:

Salivary mucin as related to oral Streptococcus mutans in elderly people. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Oral microbiology and immunology

VOLUME: 15

Page Numbers: 10-4

Journal Abbreviation: Oral Microbiol. Immunol.

ISSN: 0902-0055

DAY: 29

MONTH: Feb

YEAR: 2000

Salivary mucin as related to oral Streptococcus mutans in elderly people. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8707451

Salivary mucin as related to oral Streptococcus mutans in elderly people. Keywords Mesh Terms:

KEYWORDS: Streptococcus mutans

MESH TERMS: isolation & purification

Chemical & Substance for Abstract: Salivary mucin as related to oral Streptococcus mutans in elderly people. Information

Substance Name: Salivary Proteins

Registry Number: 0

Grant and Affiliation Information for Salivary mucin as related to oral Streptococcus mutans in elderly people.

AFFILIATION: Department of General Practice, School of Dentistry, Virginia Commonwealth University, Box 980566 MCV Station, Richmond, VA 23298-0566, USA.

Country: Denmark

AGENCY: United States NIDCR

GRANT: R01 DE 06892

ACRONYM: DE

MEDLINETA: Oral Microbiol Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Salivary mucin as related to oral Streptococcus mutans in elderly people Related Publications

• ATP site-directed kinase inhibitors.
• An overview of the role of diet during the ageing process.
• Big and tall parents do not have more sons.
• Changes in cerebral hemodynamics in preterm infants with and without patent ductus arteriosus.
• Construction of YAC libraries with large inserts.
• Dysplasia epiphysialis punctata; report of a case and review of literature.
• Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota.
• Forum on research and scholarly activity.
• Gender And Age Related Changes In Strength And Submaximal Performance Outcomes For Individuals With CHF: 2240: Board #153 June 1 8:00 AM - 9:30 AM.
• Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.
• Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
• Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.
• Phosphoinositide-3-kinases (PI3Ks): Combined Comparative Modeling and 3D-QSAR To Rationalize the Inhibition of p110alpha.
• Placement and management of long-term central venous access catheters and ports.
• Quality assurance program for peripheral blood mononuclear cell cryopreservation.
• Queuing up for quality. Boosting quality with electronic work queues.
• Retroperitoneal hemorrhage after percutaneous nephrostomy.
• Safety and Effectiveness of Progressive Resistance TVaining in Heart Failure Patients: 2242: Board #155 June 1 8:00 AM - 9:30 AM.
• Salivary mucin as related to oral Streptococcus mutans in elderly people.
• Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
• The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• The who, what, when, why and how of professional negotiations for nurses.
• Use of the balloon on a guidewire as an adjunct to conventional angioplasty.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 1.
• Women's journey of recovery from sexual assault trauma: a grounded theory--part 2.